The post Here’s what key metrics tell us about reinsurance group (RGA) Q4 earnings appeared on BitcoinEthereumNews.com. Reinsurance Group (RGA – Free Report) reportedThe post Here’s what key metrics tell us about reinsurance group (RGA) Q4 earnings appeared on BitcoinEthereumNews.com. Reinsurance Group (RGA – Free Report) reported

Here’s what key metrics tell us about reinsurance group (RGA) Q4 earnings

3 min read

Reinsurance Group (RGA – Free Report) reported $6.77 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 23.4%. EPS of $7.75 for the same period compares to $4.99 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $6.11 billion, representing a surprise of +10.86%. The company delivered an EPS surprise of +32.16%, with the consensus EPS estimate being $5.86.

While investors closely watch year-over-year changes in headline numbers — revenue and earnings — and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company’s underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock’s price performance.

Here is how Reinsurance Group performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net premiums- U.S. and Latin America- Financial Solutions: $443 million versus $218.7 million estimated by three analysts on average.
  • Net premiums- EMEA Financial Solutions: $263 million versus the three-analyst average estimate of $217.71 million.
  • Other Revenues- Asia Pacific Financial Solutions: $12 million compared to the $5.62 million average estimate based on three analysts.
  • Other Revenues- Asia Pacific Traditional: $7 million versus the three-analyst average estimate of $3.67 million.
  • Other Revenues- Canada Financial Solutions: $1 million versus the three-analyst average estimate of $4.56 million.
  • Other Revenues- Corporate and Other: $29 million versus the three-analyst average estimate of $18.92 million.
  • Other Revenues- EMEA Financial Solutions: $14 million versus $13.28 million estimated by three analysts on average.
  • Net investment income- Asia Pacific Financial Solutions: $288 million versus $252.94 million estimated by three analysts on average.
  • Net investment income- Asia Pacific Traditional: $76 million versus $74.41 million estimated by three analysts on average.
  • Net investment income: $1.69 billion versus the four-analyst average estimate of $1.49 billion. The reported number represents a year-over-year change of +42.7%.
  • Revenues- Net premiums: $4.78 billion versus the four-analyst average estimate of $4.37 billion. The reported number represents a year-over-year change of +15%.
  • Revenues- Other revenues: $299 million compared to the $322.79 million average estimate based on four analysts. The reported number represents a change of +103.4% year over year.

Want the latest recommendations from Zacks Investment Research? Download 7 Best Stocks for the Next 30 Days. Click to get this free report

Source: https://www.fxstreet.com/news/heres-what-key-metrics-tell-us-about-reinsurance-group-rga-q4-earnings-202602060728

Market Opportunity
4 Logo
4 Price(4)
$0.00913
$0.00913$0.00913
-7.21%
USD
4 (4) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.